Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.46 |
| ▸ | CCR4 | P51679 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.41 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.41 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.41 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24318836 | 0.98 | P2RX7 (0.45) | P2RX7CCR4MAPTRAB9AHTT | |
| SCHEMBL28424696 | 0.95 | KIF11 (0.44) | P2RX7CCR4MAPTRAB9AHTT | |
| SCHEMBL17546531 | 0.88 | AKR1C3 (0.45) | MAPTRAB9AHTTMEN1KMT2A | |
| SCHEMBL12320134 | 0.86 | GAA (0.45) | P2RX7MAPTRAB9AMEN1KMT2A | |
| SCHEMBL108882 | 0.85 | MAPT (0.54) | MAPTRAB9AHTTMEN1KMT2A | |
| SCHEMBL29653984 | 0.85 | MAPT (0.54) | MAPTRAB9AHTTMEN1KMT2A | |
| SCHEMBL22432439 | 0.85 | NR3C2 (0.49) | CCR4MAPTRAB9AHTTMEN1 | |
| SCHEMBL21439856 | 0.83 | MEN1 (0.62) | MAPTRAB9AHTTMEN1KMT2A | |
| SCHEMBL28194326 | 0.82 | AKR1C3 (0.49) | MAPTGAATDP1ALDH1A1TSHR | |
| SCHEMBL24948445 | 0.82 | RAB9A (0.39) | P2RX7MAPTRAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11201293-B2 | Heterocyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2021-12-14 | — | — | US | disclosed |
| CN-109863153-B | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2021-09-21 | — | — | CN | disclosed |
| EP-3564249-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2021-01-20 | — | — | EP | disclosed |
| EP-3544984-B1 | BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) | MERCK PATENT GMBH (DE) | 2020-12-23 | — | — | EP | disclosed |
| US-20190326517-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-10-24 | — | — | US | disclosed |
| US-20190326517-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-10-24 | — | — | US | disclosed |
| CN-109863153-A | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 株式会社LG化学 | 2019-06-07 | — | — | CN | disclosed |
| US-20080303425-A1 | CHRYSENES FOR BLUE LUMINESCENT APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11201293-B2 | Heterocyclic compound and organic light-emitting device comprising same | CYP1A1, CRY1, CYP1B1 | P2RX7 923/4885CCR4 3479/4885MAPT 1591/4885 |
| US-20080303425-A1 | CHRYSENES FOR BLUE LUMINESCENT APPLICATIONS | CRY2, CRY1, CYBA | P2RX7 1952/4885CCR4 2552/4885MAPT 1218/4885 |
| US-20190326517-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CYP1A1, CRY1, CYP1B1 | P2RX7 923/4885CCR4 3479/4885MAPT 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.